Φορτώνει......
A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE)
BACKGROUND: New-onset refractory status epilepticus (NORSE) is a newly defined critical disease entity characterized by prolonged periods of refractory epileptic seizure with no readily identifiable cause in otherwise healthy individuals. Its etiology is uncertain, but autoimmune encephalitis is a p...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Intensive Care |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6069820/ https://ncbi.nlm.nih.gov/pubmed/30083346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-018-0315-7 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|